BENZENO SHARON bought ADPT
November 20, 2025 · Form 4 insider transaction
BENZENO SHARON bought 68,961 shares of Adaptive Biotechnologies Corporation at $12.14 per share, a transaction worth $837.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
68,961
Price
$12.14
Total value
$837.2K
InsiderBENZENO SHARON
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 20, 2025
Filing dateNovember 24, 2025
Shares owned after594,716
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.